327 related articles for article (PubMed ID: 32850386)
1. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets.
Xu J; An P; Winkler CA; Yu Y
Front Oncol; 2020; 10():1271. PubMed ID: 32850386
[TBL] [Abstract][Full Text] [Related]
2. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
4. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y
Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
6. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D
World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435
[TBL] [Abstract][Full Text] [Related]
9. Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.
Zhu HR; Huang RZ; Yu XN; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Dong L; Janssen HLA; Shen XZ; Zhu JM
Tohoku J Exp Med; 2018 Jun; 245(2):89-98. PubMed ID: 29899182
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.
Selitsky SR; Dinh TA; Toth CL; Kurtz CL; Honda M; Struck BR; Kaneko S; Vickers KC; Lemon SM; Sethupathy P
mBio; 2015 Dec; 6(6):e01500-15. PubMed ID: 26646011
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
Huang J; Wang Y; Guo Y; Sun S
Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
[TBL] [Abstract][Full Text] [Related]
13. [MicroRNAs in hepatocarcinogenesis].
Lendvai G; Kiss A; Kovalszky I; Schaff Z
Orv Hetil; 2012 Jun; 153(25):978-89. PubMed ID: 22714032
[TBL] [Abstract][Full Text] [Related]
14. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
[TBL] [Abstract][Full Text] [Related]
15. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
16. Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma.
Qin S; Xu J; Yi Y; Jiang S; Jin P; Xia X; Ma F
Front Oncol; 2021; 11():691115. PubMed ID: 34307154
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
[TBL] [Abstract][Full Text] [Related]
18. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.
Zhang MH; Yuan YF; Liu LJ; Wei YX; Yin WY; Zheng LZ; Tang YY; Lv Z; Zhu F
World J Gastroenterol; 2023 Aug; 29(31):4706-4735. PubMed ID: 37664153
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.
Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X
Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]